15-66703278-C-A
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_005585.5(SMAD6):c.20C>A(p.Ser7*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000015 in 1,333,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. S7S) has been classified as Likely benign.
Frequency
Consequence
NM_005585.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- craniosynostosis 7Inheritance: AD, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- radioulnar synostosis, nonsyndromic, susceptibility toInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- aortic valve disease 2Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- familial bicuspid aortic valveInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital radioulnar synostosisInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
- congenital heart defects, multiple typesInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAD6 | NM_005585.5 | c.20C>A | p.Ser7* | stop_gained | Exon 1 of 4 | ENST00000288840.10 | NP_005576.3 | |
SMAD6 | NR_027654.2 | n.1043C>A | non_coding_transcript_exon_variant | Exon 1 of 5 | ||||
SMAD6 | XR_931827.3 | n.1043C>A | non_coding_transcript_exon_variant | Exon 1 of 4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMAD6 | ENST00000288840.10 | c.20C>A | p.Ser7* | stop_gained | Exon 1 of 4 | 1 | NM_005585.5 | ENSP00000288840.5 | ||
SMAD6 | ENST00000557916.5 | n.20C>A | non_coding_transcript_exon_variant | Exon 1 of 5 | 1 | ENSP00000452955.1 | ||||
SMAD6 | ENST00000612349.1 | n.202C>A | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000976 AC: 1AN: 102420 AF XY: 0.0000175 show subpopulations
GnomAD4 exome AF: 0.00000150 AC: 2AN: 1333252Hom.: 0 Cov.: 31 AF XY: 0.00000152 AC XY: 1AN XY: 658624 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Aortic valve disease 2 Uncertain:1
This sequence change creates a premature translational stop signal (p.Ser7*) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SMAD6-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at